Opus Genetics, Inc. (IRD)
NASDAQ: IRD · Real-Time Price · USD
3.980
-0.080 (-1.97%)
At close: Nov 13, 2026, 4:00 PM EST
4.095
+0.115 (2.89%)
After-hours: Nov 13, 2026, 5:59 PM EST
Opus Genetics Employees
As of December 31, 2025, Opus Genetics had 28 total employees, including 27 full-time and 1 part-time employees. The number of employees increased by 10 or 55.56% compared to the previous year. That makes Opus Genetics the 37,435th largest employer in the world and 5,211th in the United States.
Employees
28
Change (1Y)
10
Growth (1Y)
55.56%
Revenue / Employee
$282,643
Profits / Employee
-$4,880,393
Market Cap
384.68M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 28 | 10 | 55.56% | 27 | 1 |
| Dec 31, 2024 | 18 | 4 | 28.57% | 18 | 0 |
| Dec 31, 2023 | 14 | 5 | 55.56% | 14 | 0 |
| Dec 31, 2022 | 9 | 1 | 12.50% | 9 | 0 |
| Dec 31, 2021 | 8 | 3 | 60.00% | 8 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| ARS Pharmaceuticals | 206 |
| CorMedix | 191 |
| Lyell Immunopharma | 161 |
| MapLight Therapeutics | 133 |
| Assembly Biosciences | 73 |
| Rezolute | 63 |
| TRex Bio | 60 |
| Tectonic Therapeutic | 60 |
IRD News
- 3 days ago - Opus Genetics price target raised to $11 from $9 at RBC Capital - TheFly
- 4 days ago - Opus Genetics price target raised to $14 from $8 at H.C. Wainwright - TheFly
- 4 days ago - Opus Genetics reports Q3 EPS (46c), consensus (15c) - TheFly
- 4 days ago - Opus Genetics Transcript: 3rd Annual Guggenheim Healthcare Innovation Conference - Transcripts
- 5 days ago - Opus Genetics Announces Financial Results for Third Quarter 2026 and Provides Corporate Update - GlobeNewsWire
- 5 days ago - Opus Genetics Earnings release: Q3 2026 - Filings
- 5 days ago - Opus Genetics Quarterly report: Q3 2026 - Filings
- 9 days ago - Opus Genetics completes dosing in higher-dose Cohort 2 of BIRD-1 trial - TheFly